ATE432242T1 - Kristallines mesoporöses siliciumdioxid material, verwendung desgleichen für die fixation und die freisetzung von medikamenten - Google Patents

Kristallines mesoporöses siliciumdioxid material, verwendung desgleichen für die fixation und die freisetzung von medikamenten

Info

Publication number
ATE432242T1
ATE432242T1 AT04737677T AT04737677T ATE432242T1 AT E432242 T1 ATE432242 T1 AT E432242T1 AT 04737677 T AT04737677 T AT 04737677T AT 04737677 T AT04737677 T AT 04737677T AT E432242 T1 ATE432242 T1 AT E432242T1
Authority
AT
Austria
Prior art keywords
fixation
medications
release
silicon dioxide
mesoporous silicon
Prior art date
Application number
AT04737677T
Other languages
English (en)
Inventor
Johan Martens
Christine Kirschhock
Sebastien Kremer
Alexander Aerts
Den Mooter Guy Van
Humbeeck Jan Van
Original Assignee
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE432242T1 publication Critical patent/ATE432242T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5115Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B37/00Compounds having molecular sieve properties but not having base-exchange properties
    • C01B37/005Silicates, i.e. so-called metallosilicalites or metallozeosilites
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B37/00Compounds having molecular sieve properties but not having base-exchange properties
    • C01B37/02Crystalline silica-polymorphs, e.g. silicalites dealuminated aluminosilicate zeolites
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/701Integrated with dissimilar structures on a common substrate
    • Y10S977/712Integrated with dissimilar structures on a common substrate formed from plural layers of nanosized material, e.g. stacked structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/831Of specified ceramic or electrically insulating compositions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT04737677T 2003-06-27 2004-06-28 Kristallines mesoporöses siliciumdioxid material, verwendung desgleichen für die fixation und die freisetzung von medikamenten ATE432242T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0315012.5A GB0315012D0 (en) 2003-06-27 2003-06-27 Zeotiles
PCT/BE2004/000094 WO2005000740A2 (en) 2003-06-27 2004-06-28 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs

Publications (1)

Publication Number Publication Date
ATE432242T1 true ATE432242T1 (de) 2009-06-15

Family

ID=27637462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737677T ATE432242T1 (de) 2003-06-27 2004-06-28 Kristallines mesoporöses siliciumdioxid material, verwendung desgleichen für die fixation und die freisetzung von medikamenten

Country Status (15)

Country Link
US (1) US7749521B2 (de)
EP (3) EP1852393B1 (de)
JP (2) JP4709140B2 (de)
CN (1) CN100420628C (de)
AT (1) ATE432242T1 (de)
AU (1) AU2004251792B2 (de)
CA (2) CA2723328C (de)
DE (1) DE602004021256D1 (de)
DK (1) DK1638888T3 (de)
ES (2) ES2414959T3 (de)
GB (1) GB0315012D0 (de)
IL (2) IL172525A0 (de)
PL (1) PL1638888T3 (de)
WO (1) WO2005000740A2 (de)
ZA (1) ZA200510399B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273371B2 (en) * 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
US8097269B2 (en) 2004-02-18 2012-01-17 Celonova Biosciences, Inc. Bioactive material delivery systems comprising sol-gel compositions
US7981441B2 (en) 2004-02-18 2011-07-19 The Board Of Trustees Of The Leland Stanford Junior University Drug delivery systems using mesoporous oxide films
US7589041B2 (en) * 2004-04-23 2009-09-15 Massachusetts Institute Of Technology Mesostructured zeolitic materials, and methods of making and using the same
DK1809349T3 (da) * 2004-07-05 2009-12-07 Ziscoat N V Biokompatibel coating til medicinske indretninger omfattende molekylsier
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
US7776682B1 (en) * 2005-04-20 2010-08-17 Spansion Llc Ordered porosity to direct memory element formation
US20090130212A1 (en) * 2006-05-15 2009-05-21 Physical Pharmaceutica, Llc Composition and improved method for preparation of small particles
JP5546860B2 (ja) * 2006-08-16 2014-07-09 ノバルティス アーゲー 高結晶性治療化合物の固体分散体を製造するための方法
US8518363B2 (en) 2006-09-08 2013-08-27 Hitachi Chemical Company, Ltd. Method for production of carbon nanotube
US20100143423A1 (en) * 2006-12-05 2010-06-10 Michael Francis Butler Oral care product
CN101209970B (zh) * 2006-12-25 2011-06-22 上海海隼化工科技有限公司 二乙二醇单乙酯和二乙二醇双乙酯的制备方法
JP5158670B2 (ja) * 2007-02-14 2013-03-06 独立行政法人産業技術総合研究所 円筒のアルミナ細孔内における界面活性剤を鋳型としたメソポーラスシリカの構造
WO2009000286A1 (en) * 2007-06-25 2008-12-31 Parmatheen S.A. Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
US8258137B2 (en) * 2008-01-29 2012-09-04 Katholieke Universiteit Leuven Process for release of biologically active species from mesoporous oxide systems
JP5670749B2 (ja) * 2008-02-11 2015-02-18 ガルシア−ベネット, アルフォンソGARCIA−BENNETT, Alfonso メソポーラス材料を製造する方法、それにより製造された材料及びメソポーラス材料の使用
US9114125B2 (en) 2008-04-11 2015-08-25 Celonova Biosciences, Inc. Drug eluting expandable devices
TWI410279B (zh) * 2008-08-27 2013-10-01 China Steel Corp A Synthetic Method of Double - pore Molecular Sieve in Cave
JP2012506904A (ja) * 2008-10-28 2012-03-22 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 難水溶性成分のためのメソ多孔性材料賦形剤
EP2544664A1 (de) * 2010-03-11 2013-01-16 Danmarks Tekniske Universitet Unterstützte biologische wirkstoffe
CN102451158A (zh) * 2010-10-28 2012-05-16 沈阳药科大学 尼莫地平-SiO2纳米球及其制备和应用
WO2012138910A2 (en) * 2011-04-08 2012-10-11 Rive Technology, Inc. Mesoporous framework-modified zeolites
US10577250B2 (en) 2011-05-13 2020-03-03 Merck Patent Gmbh Process for producing of inorganic particulate material
KR101906792B1 (ko) * 2011-05-13 2018-10-11 메르크 파텐트 게엠베하 무기 미립자 재료의 제조 방법
CN102676494B (zh) * 2012-05-03 2013-10-30 天津大学 核壳结构固定化酶颗粒及其制备方法
US10732115B2 (en) 2012-06-22 2020-08-04 Cornell University Mesoporous oxide nanoparticles and methods of making and using same
CN113842362A (zh) * 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
EP3074344B1 (de) 2013-11-26 2020-02-12 Merck Patent GmbH Verfahren zur herstellung anorganischer partikel
WO2016145335A1 (en) * 2015-03-11 2016-09-15 Stc.Unm Generation of mesoporous materials using multiphase surfactant systems
WO2017120504A1 (en) 2016-01-08 2017-07-13 Durfee Paul N Osteotropic nanoparticles for prevention or treatment of bone metastases
US11344629B2 (en) 2017-03-01 2022-05-31 Charles Jeffrey Brinker Active targeting of cells by monosized protocells
WO2018212275A1 (ja) 2017-05-19 2018-11-22 株式会社トクヤマ 医薬原体担持体及びその製造方法
KR102140687B1 (ko) 2017-11-30 2020-08-05 한국생산기술연구원 다양한 약물의 방출 제어가 가능한 다공성 나노입자로 코팅된 임플란트
GB201803363D0 (en) 2018-03-01 2018-04-18 Sigrid Therapeutics Ab New materials and uses thereof
WO2020068798A1 (en) 2018-09-24 2020-04-02 Guo Jimin Living mammalian cells modified with functional modular nanoparticles
WO2020127281A1 (en) 2018-12-20 2020-06-25 Merck Patent Gmbh A release system comprising a bioactive agent and a particulate material
US12208164B2 (en) 2019-02-28 2025-01-28 Unm Rainforest Innovations Modular metal-organic polyhedra superassembly compositions
CN111904946B (zh) * 2019-05-10 2021-09-17 西安电子科技大学 一种基于仿生狂犬病毒的纳米诊疗制剂及其制备方法与应用
KR102368479B1 (ko) * 2020-03-03 2022-02-28 서울대학교산학협력단 나노입자 구조체 및 그 형성 방법
US20230263728A1 (en) * 2022-02-22 2023-08-24 DGP Technology Limited Biologically active additive based on mesoporous silicon dioxide and on micellar solutions of active substrates and method for preparing same
CN118925676B (zh) * 2024-07-24 2025-11-14 宁波大学 表面涂层材料、固相微萃取探针及制备方法与应用
WO2026068521A1 (en) 2024-09-24 2026-04-02 Roquette Freres Porous carrier for the delivery of poorly water-soluble substances

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639637A (en) 1968-04-23 1972-02-01 Richardson Merrell Inc Water dispersible diethylstilbestrol compositions
US4235892A (en) 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
GB8913889D0 (en) 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
US5102643A (en) 1990-01-25 1992-04-07 Mobil Oil Corp. Composition of synthetic porous crystalline material, its synthesis
US5057296A (en) * 1990-12-10 1991-10-15 Mobil Oil Corp. Method for synthesizing mesoporous crystalline material
EP0617612B1 (de) 1991-12-18 1997-09-10 Warner-Lambert Company Verfahren für die herstellung einer festen dispersion
JPH06285358A (ja) * 1993-04-06 1994-10-11 Kao Corp 徐放性金属酸化物中空微粒子及びその製造方法
US5646131A (en) 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
DE19624862A1 (de) * 1996-06-21 1998-01-02 Basf Ag Mesoporöse Oxidformkörper
HN1998000115A (es) 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
CN1277550A (zh) 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
WO1999037705A1 (en) 1997-12-09 1999-07-29 The Regents Of The University Of California Block polymer processing for mesostructured inorganic oxide materials
EP1237818B1 (de) 1999-11-23 2003-06-18 Universite Laval Mesoporöses zeolithisches material mit mikroporösen kristallinen mesoporenwänden
WO2002010218A1 (en) * 2000-07-31 2002-02-07 Drexel University Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials
US6989254B2 (en) 2000-07-31 2006-01-24 Drexel University Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials
CA2438901A1 (en) * 2001-02-21 2002-09-06 Batelle Memorial Institute Proteins in a porous support
US7846684B2 (en) 2001-02-21 2010-12-07 Battelle Memorial Institute Enzyme system comprising an enzyme bonded in a porous matrix
US6630170B2 (en) 2001-04-26 2003-10-07 Board Of Regents The University Of Texas System Mesoporous compositions and method of preparation
CN1142094C (zh) * 2001-08-24 2004-03-17 复旦大学 一种新型立方结构介孔二氧化硅分子筛的合成方法
JP4099811B2 (ja) * 2002-03-18 2008-06-11 独立行政法人産業技術総合研究所 定形多孔質シリカ乃至シリカ金属複合体粒子及びその製造方法

Also Published As

Publication number Publication date
CA2723328A1 (en) 2005-01-06
IL172525A0 (en) 2006-04-10
JP2007523817A (ja) 2007-08-23
JP5296761B2 (ja) 2013-09-25
EP1638888B1 (de) 2009-05-27
DK1638888T3 (da) 2009-08-10
ES2326651T3 (es) 2009-10-16
AU2004251792B2 (en) 2009-08-13
GB0315012D0 (en) 2003-07-30
IL213176A0 (en) 2011-07-31
US20060134219A1 (en) 2006-06-22
US7749521B2 (en) 2010-07-06
CN1812932A (zh) 2006-08-02
CN100420628C (zh) 2008-09-24
EP1852393B1 (de) 2013-04-10
JP2011063601A (ja) 2011-03-31
DE602004021256D1 (de) 2009-07-09
EP2336086A1 (de) 2011-06-22
JP4709140B2 (ja) 2011-06-22
IL213176A (en) 2016-11-30
CA2529456A1 (en) 2005-01-06
ES2414959T3 (es) 2013-07-23
PL1638888T3 (pl) 2009-10-30
EP1852393A1 (de) 2007-11-07
CA2723328C (en) 2013-02-05
WO2005000740A2 (en) 2005-01-06
WO2005000740A3 (en) 2005-02-17
AU2004251792A1 (en) 2005-01-06
ZA200510399B (en) 2006-12-27
EP1638888A2 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
ATE432242T1 (de) Kristallines mesoporöses siliciumdioxid material, verwendung desgleichen für die fixation und die freisetzung von medikamenten
CY1111126T1 (el) Σκευασμα οφθαλμικων σταγονων που περιεχει κετοτιφαινη
ATE549039T1 (de) Verfahren zur herstellung einer sterilen vorrichtung
DE60210482D1 (de) Vorrichtung und methode zur automatischen kompensation von synchronen störungen
DE60320778D1 (de) Flüssige Bleichaktivatorzusamensetzung
DE60231723D1 (de) Verfahren und vorrichtung zur herstellung von wiederverschliessbaren absorbierenden artikeln
ATE103820T1 (de) Absorbierbare beschichtung und mischung.
EP1596755A4 (de) Verfahren zur herstellung von oxidationsbeständigem polymermaterial
DE60309653D1 (de) Vorrichtung zur herstellung von thermoplastischen vliesstoffen und verbundstoffen
DE60215583D1 (de) System und Methode zur Dekonvolution des topographischen Effektes von Rastermikroskopmessungen
DE60029589D1 (de) Verfahren zur herstellung von azithromycin
DE60305200D1 (de) Aminocyclohexylether-verbindungen und deren verwendung
DE60236218D1 (de) CCR5 Antagonisten verwendbar für die Behandlung von Aids
ITMO20030057A0 (it) Dispositivo per la confezione,la miscelazione e l'applicazione di cemento osseo.
DE602006006825D1 (de) Blockcopolymere, Verfahren zu deren Herstellung und ihre Verwendung in Emulsionen
DE60020571D1 (de) Verfahren und vorrichtung zur unterscheidung und zählung von leukozyten
DE60119770D1 (de) Verfahren und vorrichtung zur oxidation von glucosemolekülen
DE50213690D1 (de) Verfahren zur charakterisierung und/oder identifizierung von wirkmechanismen antimikrobieller prüfsubstanzen
ATE344826T1 (de) Alkylmethylsiloxan- dimethylsiloxan- polyalkylenoxid- copolymere
ATE365748T1 (de) Polymer-konjugate von neublastin und methoden für deren verwendung
DE60021960D1 (de) Verfahren zur Kompensation von Neigung und/oder Defokussierung, und Vorrichtung für dasselbige
DE602004031701D1 (de) Sprühbares Klebematerial zur Lasermarkierung von Halbleiterscheiben, Chips und Vorrichtungen
DE60135128D1 (de) Vorrichtung zur Bestimmung des Gehalts an Siliciumdioxid
DE602004032465D1 (de) Referenzstandard zur charakterisierung von rosuvastatin
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1638888

Country of ref document: EP